United Therapeutics Corporation (UTHR)
NASDAQ: UTHR · Real-Time Price · USD
541.51
+1.48 (0.27%)
Oct 15, 2026, 4:00 PM EDT - Market closed
United Therapeutics Employees
United Therapeutics had 1,400 employees as of December 31, 2025. The number of employees increased by 95 or 7.28% compared to the previous year. That makes United Therapeutics the 12,541st largest employer in the world and 1,975th in the United States.
Employees
1,400
Change (1Y)
95
Growth (1Y)
7.28%
Revenue / Employee
$2,253,214
Profits / Employee
$936,357
Market Cap
23.23B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 1,400 | 95 | 7.28% |
| Dec 31, 2024 | 1,305 | 137 | 11.73% |
| Dec 31, 2023 | 1,168 | 183 | 18.58% |
| Dec 31, 2022 | 985 | 20 | 2.07% |
| Dec 31, 2021 | 965 | 15 | 1.58% |
| Dec 31, 2020 | 950 | 30 | 3.26% |
| Dec 31, 2019 | 920 | 60 | 6.98% |
| Dec 31, 2018 | 860 | 60 | 7.50% |
| Dec 31, 2017 | 800 | 50 | 6.67% |
| Dec 31, 2016 | 750 | 0 | - |
| Dec 31, 2015 | 750 | 10 | 1.35% |
| Dec 31, 2014 | 740 | 34 | 4.82% |
| Dec 31, 2013 | 706 | 83 | 13.32% |
| Dec 31, 2012 | 623 | 80 | 14.73% |
| Dec 31, 2011 | 543 | 23 | 4.42% |
| Dec 31, 2010 | 520 | 110 | 26.83% |
| Dec 31, 2009 | 410 | 50 | 13.89% |
| Dec 31, 2008 | 360 | 40 | 12.50% |
| Dec 31, 2007 | 320 | 35 | 12.28% |
| Dec 31, 2006 | 285 | 75 | 35.71% |
| Dec 31, 2005 | 210 | 40 | 23.53% |
| Dec 31, 2004 | 170 | 10 | 6.25% |
| Dec 31, 2003 | 160 | 10 | 6.67% |
| Dec 31, 2002 | 150 | 22 | 17.19% |
| Dec 31, 2001 | 128 | 18 | 16.36% |
| Dec 31, 2000 | 110 | 47 | 74.60% |
| Dec 31, 1999 | 63 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Takeda Pharmaceutical Company | 47,029 |
| Teva Pharmaceutical Industries | 33,950 |
| Viatris | 30,000 |
| Dr. Reddy's Laboratories | 27,527 |
| Haleon | 24,535 |
| Zoetis | 14,500 |
| Elanco Animal Health | 9,900 |
| Amneal Pharmaceuticals | 8,700 |
UTHR News
- 14 hours ago - United Therapeutics price target raised to $368 from $321 at Goldman Sachs - TheFly
- 1 day ago - LifeSci upgrades Liquidia to Buy on overhang clearing settlement - TheFly
- 1 day ago - Liquidia price target raised to $33 from $30 at Wells Fargo - TheFly
- 1 day ago - Liquidia upgraded at BTIG after ‘much more favorable’ than expected settlement - TheFly
- 1 day ago - Liquidia Stock (LQDA) Pops as $380.7M Deal Ends Legal Battle with United Therapeutics - TipRanks
- 2 days ago - Liquidia to pay $175M UTHR after settlement agreement - TheFly
- 2 days ago - Liquidia up 40% to $37.59 after settlement agreement with United Therapeutics - TheFly
- 2 days ago - Liquidia announces a global settlement agreement with United Therapeutics - TheFly